國立虎尾科技大學 |

Preventive and Predictive Genetics: Towards Personalised Medicine

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Preventive and Predictive Genetics: Towards Personalised Medicine/ edited by Godfrey Grech, Iris Grossman.
其他作者:	Grech, Godfrey.
面頁冊數:	XX, 378 p. 18 illus., 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Molecular biology. -
電子資源:	https://doi.org/10.1007/978-3-319-15344-5
ISBN:	9783319153445

Preventive and Predictive Genetics: Towards Personalised Medicine
Preventive and Predictive Genetics: Towards Personalised Medicine[electronic resource] /edited by Godfrey Grech, Iris Grossman. - 1st ed. 2015. - XX, 378 p. 18 illus., 8 illus. in color.online resource. - Advances in Predictive, Preventive and Personalised Medicine,92211-3495 ;. - Advances in Predictive, Preventive and Personalised Medicine,8.

Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index.

Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical research. While epidemiology and gross pathology are still mainstay useful tools, genetics and genomics have gradually been shown to increase the resolution of drug response research, showing great potential in also informing and identifying the role of genes and their encoded products in the pathophysiology of diseases. This information is already being applied in the prevention of illness, effective early diagnosis, better risk assessment (prognosis), as well as targeted effective and safe treatment allocation (prediction and monitoring). Genetic testing and genomics support personalised medicine by translating genome-based knowledge into clinical practice, offering enhanced benefit for patients and health-care systems at large. Current routine practice for diagnosing and treating patients is conducted by correlating parameters such as age, gender and weight with risks and expected treatment outcomes. In the new era of personalised medicine the healthcare provider is equipped with improved ability to prevent, diagnose, treat and predict outcomes on the basis of complex information sources, including genetic and genomic data. Targeted therapy and reliable prediction of expected outcomes offer patients access to better healthcare management, by way of identifying the therapies effective for the relevant patient group, avoiding prescription of unnecessary treatment and reducing the likelihood of developing adverse drug reactions.

ISBN: 9783319153445

Standard No.: 10.1007/978-3-319-15344-5doiSubjects--Topical Terms:

583443
Molecular biology.

LC Class. No.: QH506

Dewey Class. No.: 611.01816

Preventive and Predictive Genetics: Towards Personalised Medicine
LDR:03906nam a22004215i 4500 001 961563
003 DE-He213
005 20200703023525.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319153445 $9 978-3-319-15344-5
024 7 $a 10.1007/978-3-319-15344-5 $2 doi
035 $a 978-3-319-15344-5
050 4 $a QH506
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 611.01816 $2 23
245 1 0 $a Preventive and Predictive Genetics: Towards Personalised Medicine $h [electronic resource] / $c edited by Godfrey Grech, Iris Grossman.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XX, 378 p. 18 illus., 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Predictive, Preventive and Personalised Medicine, $x 2211-3495 ; $v 9
505 0 $a Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index.
520 $a Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical research. While epidemiology and gross pathology are still mainstay useful tools, genetics and genomics have gradually been shown to increase the resolution of drug response research, showing great potential in also informing and identifying the role of genes and their encoded products in the pathophysiology of diseases. This information is already being applied in the prevention of illness, effective early diagnosis, better risk assessment (prognosis), as well as targeted effective and safe treatment allocation (prediction and monitoring). Genetic testing and genomics support personalised medicine by translating genome-based knowledge into clinical practice, offering enhanced benefit for patients and health-care systems at large. Current routine practice for diagnosing and treating patients is conducted by correlating parameters such as age, gender and weight with risks and expected treatment outcomes. In the new era of personalised medicine the healthcare provider is equipped with improved ability to prevent, diagnose, treat and predict outcomes on the basis of complex information sources, including genetic and genomic data. Targeted therapy and reliable prediction of expected outcomes offer patients access to better healthcare management, by way of identifying the therapies effective for the relevant patient group, avoiding prescription of unnecessary treatment and reducing the likelihood of developing adverse drug reactions.
650 0 $a Molecular biology. $3 583443
650 0 $a Medical education. $3 665359
650 0 $a Systems biology. $3 600045
650 0 $a Human genetics. $3 596505
650 0 $a Pharmacology. $3 583819
650 0 $a Drug resistance. $3 872072
650 1 4 $a Molecular Medicine. $3 668353
650 2 4 $a Medical Education. $3 677657
650 2 4 $a Systems Biology. $3 683756
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Drug Resistance. $3 782695
700 1 $a Grech, Godfrey. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1256070
700 1 $a Grossman, Iris. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1256071
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319153452
776 0 8 $i Printed edition: $z 9783319153438
776 0 8 $i Printed edition: $z 9783319380575
830 0 $a Advances in Predictive, Preventive and Personalised Medicine, $x 2211-3495 ; $v 8 $3 1253856
856 4 0 $u https://doi.org/10.1007/978-3-319-15344-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)